In agreement, we observed that PRAME overexpression was correlated with its promoter hypomethylation, but only in a subset of CP‐CML samples (e.g., CP‐CML samples 8 and 11 but not CP‐CML sample 9) (Fig. 5B). Here, PRAME is linked to chronic myelogenous leukemia, BCR-ABL1 positive.